<DOC>
	<DOCNO>NCT01184859</DOCNO>
	<brief_summary>This multi-centre , randomised , placebo-controlled , double-blind , parallel-group comparative trial conduct nocturia patient . The trial design characterize dose-response relationship Minirin ( desmopressin ) Melt order establish correct dose recommendation target patient population . In particular , trial design link duration action clinical endpoint . Furthermore , trial design describe safety four different dose level desmopressin .</brief_summary>
	<brief_title>Comparative Trial Investigate Dose-Response 4 Different Dose Levels Minirin Melt Placebo</brief_title>
	<detailed_description />
	<mesh_term>Nocturia</mesh_term>
	<mesh_term>Deamino Arginine Vasopressin</mesh_term>
	<criteria>Given write informed consent prior trialrelated activity perform Aged 5575 year Mean number nocturnal void least two per night Reached postmenopause ( applicable female ) Evidence bladder outlet obstruction ( BOO ) ; urine flow less 5 mL/s ( applicable male ) A surgical treatment BOO prostatic hyperplasia within past 6 month ( applicable male ) Showing symptom follow disease mean number nocturnal void exceed four per night : Benign prostatic hyperplasia , overactive bladder , interstitial cystitis , severe stress urinary incontinence Psychosomatic habitual polydipsia Urinary retention ; post void residual volume excess 150 mL A history complication urologic malignancy ( e.g . bladder cancer prostate cancer ) Complication genitourinary pathology ( e.g . infection , stone , neoplasia ) Complication neurogenic detrusor activity Complication suspicion heart failure Uncontrolled hypertension Uncontrolled diabetes mellitus Complication hepatobiliary disease Abnormal serum creatinine level Complication hyponatraemia , serum sodium level &lt; 135 mEq/L Central nephrogenic diabetes insipidus ( CDI NDI ) Syndrome inappropriate antidiuretic hormone ( SIADH ) Obstructive sleep apnea Alcohol dependency drug abuse A job lifestyle may interfere regular nighttime sleep Previous desmopressin treatment Treatment another investigational product within past 3 month A need treatment prohibit concomitant drug complication problem A mental condition , lack decisionmaking ability , dementia speech handicap Any reason Investigator believe inappropriate</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>nocturia</keyword>
	<keyword>bladder function</keyword>
</DOC>